ArticleHaematologica2026

Bortezomib-melphalan-prednisone <I>versus</i> lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial.

Sara Bringhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.